| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 88 |
| 1 | PREDNISONE | 75 |
| 2 | ERGOCALCIFEROL | 60 |
| 3 | DENOSUMAB | 59 |
| 4 | POTASSIUM NITRATE, SODIUM FLUORIDE | 56 |
| 5 | ACETAMINOPHEN | 55 |
| 6 | POTASSIUM NITRATE AND SODIUM FLUORIDE | 49 |
| 7 | BUDESONIDE | 43 |
| 8 | AMLODIPINE | 39 |
| 9 | DIPHENHYDRAMINE HYDROCHLORIDE | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POTASSIUM NITRATE, SODIUM FLUORIDE | 56 | 0.0875 |
| 1 | POTASSIUM NITRATE AND SODIUM FLUORIDE | 49 | 0.0848 |
| 2 | STANNOUS FLUORIDE | 22 | 0.0305 |
| 3 | PEMIVIBART | 1 | 0.0233 |
| 4 | BETIBEGLOGENE AUTOTEMCEL | 1 | 0.0179 |
| 5 | ATRASENTAN | 1 | 0.0099 |
| 6 | TALETRECTINIB | 1 | 0.0092 |
| 7 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0055 |
| 8 | FUTIBATINIB | 1 | 0.0045 |
| 9 | PHENAZOPYRIDINE HYDROCHLORIDE | 1 | 0.0030 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 178 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 107 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 88 |
| 3 | Kinase Inhibitor [EPC] | 73 |
| 4 | Provitamin D2 Compound [EPC] | 60 |
| 5 | RANK Ligand Inhibitor [EPC] | 59 |
| 6 | Vitamin C [EPC] | 51 |
| 7 | Benzodiazepine [EPC] | 50 |
| 8 | Proton Pump Inhibitor [EPC] | 50 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 45 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenocorticotropic Hormone [EPC] | 3 | 0.0034 |
| 1 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 2 | Provitamin D2 Compound [EPC] | 60 | 0.0020 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 4 | Interferon alfa-2b [EPC] | 2 | 0.0011 |
| 5 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 6 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 2 | 0.0009 |
| 7 | Complement 5a Receptor Antagonist [EPC] | 6 | 0.0009 |
| 8 | Parathyroid Hormone-Related Peptide Analog [EPC] | 22 | 0.0007 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |